Physician profile
John M Mesa
NPI 1982783890
$1,108.16
in general payments reported to CMS, 2019-2025
7 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $139 · 2021: $262 · 2022: $124 · 2023: $16.52 · 2024: $214 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $361.04 | 2019-2022 | |
| Revance Therapeutics, INC. | $349.85 | 2024-2025 | Daxxify |
| Acelrx Pharmaceuticals, INC. | $145.93 | 2021 | |
| Allergan, INC. | $101.71 | 2019-2021 | |
| Apyx Medical Corporation | $76.42 | 2020 | |
| Mentor Worldwide LLC | $56.69 | 2021 | |
| Abbvie INC. | $16.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mesa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.